PT SOHO Global Health Tbk Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04689984
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PT SOHO Global Health Tbk

Active Ingredients

Drugs in Phase 3 Trials (3)

astaxanthin (1 trial)

b multivitamins (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 3)

Pain (Phase 3)

Peripheral Nervous System Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3